- Exchange: London
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Summit Therapeutics PLC+ Add to Watchlist
SUMM:LN153.0000 GBp 0.00000.00%
As of 03:52:27 ET on 03/27/2015.
Company Profile for Summit Therapeutics PLC (SUMM)
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
Summit Therapeutics PLC
Key Executives for Summit Therapeutics PLC (SUMM)
|Glyn O EdwardsChief Executive Officer||Erik OstrowskiChief Financial Officer|